Medtronic plc

NYSE:MDT 株式レポート

時価総額:US$107.9b

Medtronic マネジメント

マネジメント 基準チェック /24

Medtronicの CEO はGeoff Marthaで、 Apr2020年に任命され、 の在任期間は 4.58年です。 の年間総報酬は$ 20.08Mで、 6.7%給与と93.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.006%を直接所有しており、その価値は$ 6.49M 。経営陣と取締役会の平均在任期間はそれぞれ3.6年と7.8年です。

主要情報

Geoff Martha

最高経営責任者

US$20.1m

報酬総額

CEO給与比率6.7%
CEO在任期間4.6yrs
CEOの所有権0.006%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間7.8yrs

経営陣の近況

Recent updates

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Oct 13
Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Medtronic: Undervalued Dividend Aristocrat With High Margins

Oct 10

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Sep 30
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Sep 16
Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Sep 16

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Sep 05
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Is The Company Back?

Aug 26

Medtronic: Still A Buy Before Earnings

Aug 17

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Aug 08
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

Jul 16

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Jul 11
At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27
Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26
Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01
Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

CEO報酬分析

Medtronic の収益と比較して、Geoff Martha の報酬はどのように変化したか?
日付総報酬給与会社業績
Oct 25 2024n/an/a

US$4b

Jul 26 2024n/an/a

US$4b

Apr 26 2024US$20mUS$1m

US$4b

Jan 26 2024n/an/a

US$4b

Oct 27 2023n/an/a

US$4b

Jul 28 2023n/an/a

US$4b

Apr 28 2023US$15mUS$1m

US$4b

Jan 27 2023n/an/a

US$4b

Oct 28 2022n/an/a

US$4b

Jul 29 2022n/an/a

US$5b

Apr 29 2022n/an/a

US$5b

Jan 28 2022n/an/a

US$5b

Oct 29 2021n/an/a

US$5b

Jul 30 2021n/an/a

US$4b

Apr 30 2021US$18mUS$1m

US$4b

Jan 29 2021n/an/a

US$3b

Oct 30 2020n/an/a

US$4b

Jul 31 2020n/an/a

US$4b

Apr 24 2020US$6mUS$905k

US$5b

Jan 24 2020n/an/a

US$5b

Oct 25 2019n/an/a

US$5b

Jul 26 2019n/an/a

US$4b

Apr 26 2019US$4mUS$693k

US$5b

報酬と市場: Geoffの 総報酬 ($USD 20.08M ) は、 US市場 ($USD 12.73M ) の同規模の企業の平均を上回っています。

報酬と収益: Geoffの報酬は過去 1 年間で 20% 以上増加しました。


CEO(最高経営責任者

Geoff Martha (54 yo)

4.6yrs

在職期間

US$20,084,630

報酬

Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Director of NextEra...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Geoffrey Martha
Chairman of the Board & CEO4.6yrsUS$20.08m0.0060%
$ 6.5m
Sean Salmon
Executive VP & President of Cardiovascular Portfoliono dataUS$6.55m0.0021%
$ 2.3m
Brett Wall
Executive VP & President of Neuroscience Portfolio5yrsUS$6.44m0.00092%
$ 992.4k
Gregory Smith
Executive Vice President of Global Operations & Supply Chain3.6yrsUS$7.66m0.0015%
$ 1.6m
Gary Corona
Senior Vice President of Global Financial Planning and Analysis & Interim CFOless than a yearデータなし0.00045%
$ 485.4k
Mark Ploof
Senior Vice President of Global Operations and Business Services8.1yrsデータなしデータなし
Jennifer Kirk
Senior VP3.4yrsデータなし0.0022%
$ 2.4m
Kenneth Washington
Senior VP and Chief Technology & Innovation Officer1.4yrsデータなしデータなし
Laura Mauri
Senior VP and Chief Scientific & Medical Officer2.6yrsデータなしデータなし
Ryan Weispfenning
VP & Head of Investor Relations9.4yrsデータなしデータなし
Ivan Fong
Executive VP2.8yrsUS$11.72m0.0019%
$ 2.0m
Torod Neptune
Senior VP & Chief Communications Officer3.8yrsデータなしデータなし

3.6yrs

平均在職期間

59yo

平均年齢

経験豊富な経営陣: MDTの経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Geoffrey Martha
Chairman of the Board & CEO5yrsUS$20.08m0.0060%
$ 6.5m
Scott Donnelly
Independent Director11.8yrsUS$365.06k0.0012%
$ 1.3m
Kendall Powell
Independent Director17.8yrsUS$350.06k0.0015%
$ 1.6m
Randall Hogan
Independent Director9.8yrsUS$385.06k0.0034%
$ 3.6m
Craig Arnold
Lead Independent Director9.8yrsUS$410.06k0.0028%
$ 3.0m
Andrea Goldsmith
Independent Director5.7yrsUS$370.06k0.00048%
$ 517.8k
Elizabeth Nabel
Independent Director10.8yrsUS$370.06k0.0010%
$ 1.1m
Lidia Fonseca
Independent Director2.4yrsUS$350.06k0.00012%
$ 129.4k
Kevin Lofton
Independent Director4.2yrsUS$370.06k0.00032%
$ 345.2k
Gregory Lewis
Independent Director1.4yrsUS$306.97k0%
$ 0

7.8yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: MDTの 取締役会経験豊富 であると考えられます ( 7.8年の平均在任期間)。